Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation

被引:3
作者
Dams, Gregory M. [2 ,3 ]
Ketchen, Bethany R. [4 ]
Burden, Jennifer L. [5 ]
Smith, Noelle B. [1 ,6 ]
机构
[1] Yale Univ, Yale Sch Med, Dept Psychiat, New Haven, CT USA
[2] Salem Vet Affairs Med Ctr, Salem, VA USA
[3] VA Program Evaluat & Resource Ctr, 795 Willow Rd, Menlo Pk, CA 94025 USA
[4] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA
[5] Vet Hlth Adm, Dept Vet Affairs, Salem, VA USA
[6] VA Northeast Program Evaluat Ctr, West Haven, CT USA
关键词
Propensity score matching; Veterans; Mental health; Substance use disorder; Residential treatment; SEVERE MENTAL-ILLNESS; PEOPLE;
D O I
10.1016/j.drugalcdep.2024.111081
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Prior reviews of substance use disorder (SUD) treatment have found mixed support for residential level of care but are limited by methodology problems and the ethical concerns of randomizing patients with severe SUD to lower levels of care. Methods: The present study is the first to use a large archival SUD residential sample with a matched comparison group and one-year follow-up period to examine the benefits of residential treatment provided to adults clinically assessed as warranting SUD residential care. We used propensity score matching in our sample (N = 6177) of veterans with a SUD who were screened and accepted for Veterans Affairs (VA) SUD residential treatment between January 1st, 2019 and June 30th, 2019. Results: We found evidence that VA SUD residential treatment saves veteran lives with an average 66% all-cause mortality risk reduction during the study period (b = -1.09, exp(b) = 0.34, p <0.001). Medium-to-large residential pre- to post-treatment self-reported mental health and SUD symptom improvements (|SMDrobust| = 0.54-0.93) were sustained by one-year post-screening. These residential treatment improvements were significantly larger than estimated counterfactual outcomes across self-reported SUD and stress disorder symptoms at one-year post-screening (ps <0.001). We found mixed behavioral, service utilization, and other self-reported mental health outcomes. Conclusions: We conclude that VA SUD residential treatment is an effective level of care for veterans warranting residential care particularly for SUD symptom improvements and reductions in mortality risk.
引用
收藏
页数:8
相关论文
共 53 条
  • [1] Agency for Healthcare Research and Quality [AHRQ], 2020, National healthcare quality and disparities report: Chartbook on healthcare for veterans
  • [2] Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review
    Ali, M. Sanni
    Groenwold, Rolf H. H.
    Belitser, Svetlana V.
    Pestman, Wiebe R.
    Hoes, Arno W.
    Roes, Kit C. B.
    de Boer, Anthonius
    Klungel, Olaf H.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (02) : 122 - 131
  • [3] [Anonymous], 2022, 2020 National Survey on Drug Use and Health: Women
  • [4] [Anonymous], 2020, 2019 national survey on drug use and health: American Indians and Alaska Natives (AI/ANs)
  • [5] [Anonymous], 2000, STAT BIOL HEALTH, DOI 10.1007/978-1-4757-3294-8_3
  • [6] Arel-Bundock V., 2023, MARGINALEFFECTS PRED
  • [7] Baraldi A. N., 2013, The oxford handbook of quantitative methods: Statistical analysis, P635
  • [8] Veteran drug overdose mortality, 2010-2019
    Begley, Mark R.
    Ravindran, Chandru
    Peltzman, Talya
    Morley, Sybil W.
    Stephens, Brady M.
    Ashrafioun, Lisham
    McCarthy, John F.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2022, 233
  • [9] Substance Use Disorders Among Veterans in a Nationally Representative Sample: Prevalence and Associated Functioning and Treatment Utilization
    Boden, Matthew Tyler
    Hoggatt, Katherine J.
    [J]. JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2018, 79 (06) : 853 - 861
  • [10] A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders
    Brunette, MF
    Mueser, KT
    Drake, RE
    [J]. DRUG AND ALCOHOL REVIEW, 2004, 23 (04) : 471 - 481